Study on Reparixin for Pneumonia Patients

This study tests if a medicine called reparixin helps people with pneumonia, including COVID-19, get better faster. Pneumonia is a lung infection. The study is happening in many places and involves 526 adults who are in the hospital because of pneumonia. Patients will get either reparixin or a placebo, which looks like the medicine but has no effect, for up to 21 days. Both groups will also get regular treatment for pneumonia.

Key Points:

• Participants will be in the study for up to 180 days and will visit the hospital for check-ups.
• The study checks if reparixin helps patients recover faster and stay off ventilators.
• Safety and side effects of reparixin will be carefully monitored.

To join, you need to be at least 18 years old, have pneumonia symptoms like a cough, and need extra oxygen. You cannot join if you have severe liver or kidney problems, or if you're pregnant. The study will not pay you, but you will get the standard care for your illness.